Quick answer: No, AlphaFlo® and stem cell therapies are different categories of products. AlphaFlo® is an acellular, canine amniotic tissue allograft derived from placental tissue. A stem cell therapy, by contrast, is comprised of living cells extracted from a patient’s tissues such as fat or bone marrow. The distinction is not simply a matter of how much cellular material a product contains. It is a fundamental difference in composition and biological function. This gets blurred often in casual conversation, at conferences, and sometimes in exam rooms, so it is worth walking through clearly.

Why the terminology gets mixed up

Regenerative and orthobiologic veterinary medicine cover a wide range of approaches, including platelet rich plasma, autologous stem cell therapy, cultured cell products, and tissue allografts. These approaches are often grouped together in conversation because they share a broad objective: supporting the body’s own healing processes. The terminology can also be confusing because the field continues to evolve, with new products and technologies entering clinical use. Understanding the distinction makes it easier to describe what AlphaFlo® is and what it is not.

What cellular and acellular actually mean

A cellular product contains living cells intended for implantation, transplantation, infusion, or transfer into the patient. Stem cell therapies are a common example. In an autologous stem cell approach, for example, tissue is collected from the patient, typically fat or bone marrow, processed to isolate or expand the cell population, and then reintroduced into that same patient. In this type of therapy, the living cells are the central component of the administered material which depends on their survival and interaction with the body to elicit their biological functions.

AlphaFlo® is different. It is an acellular, canine amniotic tissue allograft and does not contain or depend on viable cells for its biological function. Instead, the tissue-derived product contains biological components native to amniotic tissue, including extracellular matrix proteins, growth factors, cytokines and other naturally occurring components. That distinction is important as AlphaFlo® is not a stem cell preparation, but rather a product containing biologically active amniotic tissue components.

Sourcing and format

Canine amniotic tissue used to produce AlphaFlo® is recovered during scheduled deliveries by licensed veterinarians, using safe recovery techniques and sterile equipment, without harm to the donor animal or puppies. The product is manufactured aseptically in a controlled environment and tested to USP standards before release.

AlphaFlo® is supplied as a cryopreserved liquid, and maintained frozen until use to maintain protein stability and biological functions of the tissue. It is available for administration by licensed veterinarians only, and is not sold directly to, or intended for administration by pet owners.

Why the distinction matters in practice

The distinction between a stem cell therapy and an acellular tissue allograft is more than a matter of terminology. It affects how veterinarians describe a product, communicate expectations, discuss its composition, and answer important client questions. Making that distinction helps keep the conversations with pet owners grounded in what the product actually contains, regardless of what a colleague, a sales representative from a different company, or a client’s internet search has suggested.

Quick reference

Is AlphaFlo® a stem cell therapy?
No. It is an acellular tissue allograft. It does not contain living cells intended for transfer into the patient.

Does AlphaFlo® contain living cells?
No. It is acellular by design and by processing.

Is AlphaFlo® the same category as PRP?
No. Platelet rich plasma is derived from the patient’s own blood and typically prepared chairside. It is a separate modality from an off-the-shelf tissue allograft, even though both are used within veterinary regenerative medicine.

If this is a question you are fielding from colleagues, referring practices, or pet owners, AlphaLogix is glad to walk through it in more detail. Reach out directly, or join an upcoming Lunch and Learn session to see where AlphaFlo® fits within a broader treatment plan.